Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |
mRNA | IGFBPL1 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-11 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-10 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-10 |